Applied Biosystems Advances PCR with New Thermal Cycler Technology

FOSTER CITY, Calif.--(BUSINESS WIRE)--Applied Biosystems (NYSE: ABI), an Applera Corporation business, today announced a first-of-its-kind, temperature-control technology that is expected to increase the accuracy and efficiency of the process of performing the polymerase chain reaction (PCR) – a widely used laboratory technique for duplicating nucleic acids. The new proprietary technology used in VeriFlex™ Blocks, is being introduced in the new Veriti™ 96-Well Thermal Cycler. This technology enables researchers to rapidly find optimal reaction temperatures and accurately perform simultaneous mixed-temperature reactions.

MORE ON THIS TOPIC